et al.. Evaluation of novel H1N1-specific primer-probe sets using commercial RT-PCR mixtures and a premixed reaction stored in a lyophilized format
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Page 1 of 10 A c c e p t e d M a n u s c r i p t ase UNG, 800 nM of forward primer, 800 nM of reverse primer and 400 nM of probe. 2 min at 50°C, 40 min at 60°C, 5 min at 95 °C followed by 45 cycles of 95 °C for 15 sec., 55 °C (60 °C for HKU primer-probe set 2) for 1 min. Kit 2 (AgPath-ID One-Step RT-PCR Kit):
--PCR master mix reagent, 800 nM of forward primer, 800 nM of reverse primer and 400 nM of probe. 30 min at 50°C, 10 min at 95 °C followed by 45 cycles of 95 °C for 15 sec., 55 °C (60 °C for HKU primer-probe set 2) for 45 sec. Kit 3 (RNA UltraSense One-Step Quantitative RT-PCR System):
, 800 nM of forward primer, 800 nM of reverse primer and 400 nM of probe. 30 min at 50°C, 2 min at 95 °C followed by 45 cycles of 95 °C for 15 sec., 55 °C (60 °C for HKU primer-probe set 2) for 45 sec. Lyophilized bead format: 30 min at 48°C, 2 min at 95 °C followed by 45 cycles of 95 °C for 15 sec., 60 °C for 45 sec. CDC protocol (SuperScript III Platinum One-Step Quantitative RT-PCR kit) (WHO, 2009c) : 30 min at 50°C, 2 min at 95 °C followed by 45 cycles of 95 °C for 15 sec., 55 °C (60 °C for HKU primer-probe set 2) for 30 sec.
A c c e p t e d M a n u s c r i p t M a n u s c r i p t 2 detection limit of the lyophilized reaction mixture was found to be 1.68E-05 TCID 50 per reaction, but the amplification efficiency of the assay was lower than those deduced from the other assays. All respiratory samples from infected patients and all control nasopharyngeal aspirates were positive and negative, respectively, in the newly developed assay. The results highlighted that, to enhance the sensitivity of an assay, it is essential to evaluate a primer-probe set with different commercial RT-PCR assays.
This study also demonstrated the feasibility of using lyophilized reaction mixtures for the molecular diagnosis of novel H1N1. (Dawood et al., 2009; Fraser et al., 2009) and the disease has spread subsequently around the world within weeks. Several molecular diagnostic tests have been developed for detecting this novel human virus (Carr et al., 2009; Ellis et al., 2009; Fraser et al., 2009; Lau et al., 2009; Mahony et al., 2009; Poon et al., 2009; Wang et al., 2009) Several real-time quantitative RT-PCR assays for the novel H1N1 diagnosis were developed during the early phase of the pandemic (Fraser et al., 2009; Poon et al., 2009) . In this study, some of these HA-specific assays were further optimized by testing Primer-probe sets developed from previous reports were evaluated in this study (Fraser et al., 2009; Poon et al., 2009 ). Viral RNA in culture supernatant of MDCK cells infected with A/California/04/2009 was extracted as described ). (Table 1) . As shown in Table 1 , the detection limit of the assay was comparable to those deduced from the most sensitive assays in this study (1.68E-05 TCID 50 per reaction). However, those reactions with a more concentrated RNA input (1.68 to 1.68E-02 TCID 50 per reaction) were found to have a Ct value that is 2-4 cycles greater than those of the corresponding reactions from RT-PCR Kits 1-3. These results suggested that the reverse transcription and/or DNA amplification of this test might not be very efficient. All negative control samples (nasopharyngeal aspirate samples, N=30) and all respiratory samples from confirmed pandemic (H1N1) 2009 infected patients (N=29) were found to be negative and positive, respectively, in the test. All reactions were positive for the IPC.
In this study, the performances of 3 primer-probe sets in 3 different commercially available RT-PCR assays were compared. It was demonstrated that some of these combinations might have a better sensitivity and amplification efficiency. Nonetheless, some of these primer-probe sets were found to be performed poorly in some settings (e.g. HKU primer-probe set 1 in reaction from RT-PCR Kit 3). These results highlighted the importance of performing systematic assay optimizations.
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The WHO recommended HA-specific real-time RT-PCR assay (WHO, 2009c) , supplied by the USA CDC, was evaluated previously by others and the assay was found to be 10 folds less sensitive than other established real-time assays (Ellis et al., 2009 ).
Similar results were obtained in the initial work of this study (data not shown). This might due to the fact that the kit was only transported with chilled ice packs, suggesting the quality of the enzymes in the kit might be affected by the improper shipping method.
Indeed, the sensitivity of the assay was found to be enhanced when a new batch of enzyme mixture was used in the work (Table 1) .
In order to reduce the manpower and turnaround time for the molecular detection of pandemic influenza A (H1N1) 2009 virus, a ready-to-use premixed RT-PCR was converted into a lyophilized bead format. The presence of an internal positive control in the reaction could help to identify samples that might contain PCR inhibitors. In addition, it is expected that the simplified procedures might help to reduce human errors and PCR contaminations. In order to improve the sensitivity and amplification efficiency, the lyophilized reagents and the assay condition are currently under further optimization.
